Cargando…
Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels
Gut microbiota has a proven role in regulating multiple neuro-chemical pathways through the highly interconnected gut-brain axis. Oral bacteriotherapy thus has potential in the treatment of central nervous system-related pathologies, such as Alzheimer’s disease (AD). Current AD treatments aim to pre...
Autores principales: | Bonfili, Laura, Cecarini, Valentina, Berardi, Sara, Scarpona, Silvia, Suchodolski, Jan S., Nasuti, Cinzia, Fiorini, Dennis, Boarelli, Maria Chiara, Rossi, Giacomo, Eleuteri, Anna Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445077/ https://www.ncbi.nlm.nih.gov/pubmed/28546539 http://dx.doi.org/10.1038/s41598-017-02587-2 |
Ejemplares similares
-
SLAB51 Probiotic Formulation Activates SIRT1 Pathway Promoting Antioxidant and Neuroprotective Effects in an AD Mouse Model
por: Bonfili, Laura, et al.
Publicado: (2018) -
Targeting Proteolysis with Cyanogenic Glycoside Amygdalin Induces Apoptosis in Breast Cancer Cells
por: Cecarini, Valentina, et al.
Publicado: (2022) -
Flavan‐3‐ol Microbial Metabolites Modulate Proteolysis in Neuronal Cells Reducing Amyloid‐beta (1‐42) Levels
por: Cecarini, Valentina, et al.
Publicado: (2021) -
Gut Microbiome and Mycobiome Alterations in an In Vivo Model of Alzheimer’s Disease
por: D’Argenio, Valeria, et al.
Publicado: (2022) -
Neuroprotective effects of p62(SQSTM1)-engineered lactic acid bacteria in Alzheimer’s disease: a pre-clinical study
por: Cecarini, Valentina, et al.
Publicado: (2020)